tradmap

MIRA Earnings MIRA PHARMACEUTICALS, INC.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$1 -$1 $0 2022 2023 2024 2025
EPS
Net income (annual)
-$12M -$6M $0 2022 2023 2024 2025
Net income
Return on equity (annual)
-357% 413% 1184% 0% 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$1 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$6M -$3M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-270% -135% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–17 of 17
Q2 20262026-06-30-0.062026-08-1210-Q
Q1 20262026-03-31-0.032026-05-1410-Q
FY 20252025-12-31-1.352026-03-3110-K
Q3 20252025-09-30-1.452025-11-1310-Q
Q2 20262025-06-30-0.192026-08-1210-Q
Q1 20262025-03-31-0.112026-05-1410-Q
FY 20252024-12-31-0.512026-03-3110-K
Q3 20252024-09-30-0.362025-11-1310-Q
Q2 20252024-06-30-0.232025-08-1410-Q
Q1 20252024-03-31-0.152025-05-1410-Q
FY 20242023-12-31-0.852025-03-2810-K
Q3 20242023-09-30-0.452024-11-1210-Q
Q2 20242023-06-30-0.202024-08-1310-Q
Q1 20242023-03-31-0.102024-05-1310-Q
FY 20232022-12-31-0.402024-04-0110-K
Q3 20232022-09-30-0.432023-11-1310-Q
Q2 20232022-06-30-0.302023-09-1510-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.